Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

We tested more than 110 sunscreens over the course of six weeks and ranked them. See which brands like EltaMD, Supergoop & ...

demonstrates that initiating ruxolitinib cream therapy for atopic dermatitis (AD) significantly reduced patients’ reliance on other topical treatments, oral corticosteroids, and biologics in ...

has been battling painful dermatitis on her hands, and despite her efforts no treatment has alleviated the issue. The 52-year-old tried various steroid creams, body lotions, and dermatologist ...

Data that shows reduction in disease severity and symptom improvementThe ZORYVE cream 0.15% clinical trial program showed its potential in effectively managing the symptoms of atopic dermatitis.

"ZORYVE cream 0.15% offers significant promise for patients with atopic dermatitis, particularly in addressing the distressing itch and skin eruptions that can disrupt daily life," said Dr ...

The best time to apply the cream is right after getting out of the shower, which will help lock in hydration. The most common prescription treatment for dermatitis is a topical corticosteroid ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

New patient-reported outcome data from INTEGUMENT-1 and -2 demonstrate that ZORYVE cream 0.15% rapidly decreased the impact of atopic dermatitis (AD), including sleep loss and daily activities ...